Natalie Dakers is an accomplished leader in the biotechnology and pharmaceutical sectors, currently serving as the Chief Executive Officer of A2O Advanced Materials Inc. since January 2021. Dakers holds multiple board positions, including on the boards of Integrated Nanotherapeutics Inc., Sonic Incytes Medical Corp., Augurex Life Sciences Corp., and LifeLabs Medical Laboratory Services, demonstrating extensive expertise in governance. Dakers also contributes to academia as an Adjunct Professor at The University of British Columbia. Previous accomplishments include founding and leading Accel-Rx Health Sciences Accelerator, which raised $15 million to support early-stage health innovation, and founding CDRD Ventures Inc. to commercialize technologies in drug development. Dakers earned a Bachelor of Science in Marine Biology from The University of Guelph.
This person is not in the org chart
This person is not in any teams
This person is not in any offices